your badges 52W Range $1–$16 0% of range Analyst Rating BUY 6 analysts Price Target $17 +1091% upside P/E · ROE -174.7% Net Profit Margin -2057.5%

RADX Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

03
Price $1.42
EPS $-1.79
Revenue $3M
ROE -174.7%
52W Range $1–$16

RADX Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

04
range
bars

Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.

10-Year Performance Revenue, net income, margins and EPS trends

06
Revenue$3M
2024-06-30 → 2026-06-30
EPS$-1.79
2023-06-30 → 2026-06-30
Net margin-2057.5%
2025-06-30 → 2026-06-30
Valuation & Ratios 07–12

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

No data for this ratio group yet

Not enough fundamentals data to compute this ratio group yet.

value · ≈ 5Y avg · industry median · verdict relative to median

Full Fundamentals All metrics by year — income statement, balance sheet, cash flow

15
Income Statement 15
Metric Trend 202620252024
Revenue $3M$4M$299.2K
Cost of Revenue $3M$4M·
Gross Profit $263.4K$39.3K$299.2K
R&D Expense $50M$28M$23M
SG&A Expense $16M$15M$13M
Operating Income $-57M$-38M$-47M
Interest Expense $112.4K$65.3K$642.9K
Pretax Income $-57M$-38M$-48M
Income Tax $54.4K$103.3K$96.4K
Net Income $-57M$-38M$-48M
EPS (Basic) $-1.79$-1.76$-12.41
EPS (Diluted) $-1.79$-1.76$-12.41
Shares (Basic) 3,073,344,0672,081,058,451386,460,137
Shares (Diluted) 3,073,344,0672,081,058,451386,460,137
EBITDA $-57M$-38M·
Balance Sheet 10
Metric Trend 202620252024
Cash & Equivalents $4M$29M$19M
Receivables $17M$10M$987.4K
Current Assets $22M$40M$23M
PP&E (Net) $46.1K$53.5K$60.8K
Intangibles $38M$47M$49M
Total Assets $60M$86M$72M
Accounts Payable $11M$9M$11M
Current Liabilities $19M$15M$18M
Total Liabilities $38M$44M$45M
Stockholders' Equity $22M$43M$27M
Cash Flow 3
Metric Trend 202620252024
Operating Cash Flow $-53M$-37M$-23M
Investing Cash Flow $-5M$2M$-320.0K
Financing Cash Flow $33M$45M$30M
Profitability 8
Metric Trend 202620252024
Gross Margin 9.5%1.1%·
Operating Margin -2051.5%-1050.6%·
Net Margin -2057.5%-1055.3%·
Pretax Margin -2055.6%-1052.4%·
EBITDA Margin -2051.5%-1050.6%·
ROA -77.7%-48.4%·
ROE -174.7%-109.2%·
ROIC -254.6%-89.3%·
Liquidity & Solvency 3
Metric Trend 202620252024
Current Ratio 1.22.7·
Quick Ratio 1.12.6·
Interest Coverage -505.2-584.6·
Efficiency 2
Metric Trend 202620252024
Asset Turnover 0.00.0·
Receivables Turnover 0.20.6·
Per Share 3
Metric Trend 202620252024
Revenue / Share $0.00$0.00·
Cash Flow / Share $-0.02$-0.02·
EPS (TTM) $-1.79$-1.76·
Valuation (TTM) 4
Metric Trend 202620252024
Revenue TTM $3M$4M·
Net Income TTM $-57M$-38M·
P/E ·-2.6·
Earnings Yield ·-37.9%·

Most recent period on the left · null values shown as ·

Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years

16
Metric 2026-06-302025-06-302024-06-302023-06-30
Revenue $3M $4M $299.2K ·
Gross Margin % 9.5% 1.1% · ·
Operating Margin % -2051.5% -1050.6% · ·
Net Income $-57M $-38M $-48M $-35M
Diluted EPS $-1.79 $-1.76 $-12.41 $-11.32

Institutional owners (13F) 6 filers · $1.2M total · As of June 30, 2026

17

Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.

Holders 6
Value held $1.2M
New positions 0
Exited positions 1
Institutional activity — Q2 2026 vs prior quarter
New positions Exited positions Increased Decreased Net shares change
0 (0 vs prior Q) 1 (-3 vs prior Q) 3 (+2 vs prior Q) 1 (-2 vs prior Q) -184K

Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.

Institution Value Shares % of tracked 13F Type
Stonepine Capital Management, LLC $670,500 51,000,000 56.66% Shares
HSBC HOLDINGS PLC $253,727 62,188 21.44% Shares
Regal Partners Ltd $168,178 40,138 14.21% Shares
PNC Financial Services Group, Inc. $83,800 20,000 7.08% Shares
UBS Group AG $6,314 1,507 0.53% Shares
RHUMBLINE ADVISERS $817 195 0.07% Shares

RADX Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

21
rating · 6 analysts BUY
Median target $15.24 +972.9%
1 16.7% Strong Buy
4 66.7% Buy
1 16.7% Hold
0 0.0% Sell
0 0.0% Strong Sell

12-Month Price Target

6 analysts · 2026-10-01

Mean target $16.91 +1090.7%

← Below all targets Current price $1.42
Low$12.39 Mean$16.91 High$29.88

Latest News Recent headlines mentioning this company

23
Radiopharm Theranostics Signs Supply Deal With Siemens Healthineers For RAD101 Nasdaq · 5 months, 3 weeks ago

My Metrics Your personal watchlist — selected rows from Full Fundamentals

26

Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.

Source: SEC 20-F filed Sep 30, 2026